全文获取类型
收费全文 | 10353篇 |
免费 | 730篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 333篇 |
妇产科学 | 221篇 |
基础医学 | 1798篇 |
口腔科学 | 546篇 |
临床医学 | 759篇 |
内科学 | 2190篇 |
皮肤病学 | 242篇 |
神经病学 | 908篇 |
特种医学 | 179篇 |
外科学 | 1069篇 |
综合类 | 52篇 |
一般理论 | 5篇 |
预防医学 | 950篇 |
眼科学 | 228篇 |
药学 | 755篇 |
中国医学 | 91篇 |
肿瘤学 | 684篇 |
出版年
2023年 | 82篇 |
2022年 | 194篇 |
2021年 | 396篇 |
2020年 | 248篇 |
2019年 | 312篇 |
2018年 | 400篇 |
2017年 | 245篇 |
2016年 | 301篇 |
2015年 | 298篇 |
2014年 | 465篇 |
2013年 | 571篇 |
2012年 | 863篇 |
2011年 | 879篇 |
2010年 | 475篇 |
2009年 | 389篇 |
2008年 | 709篇 |
2007年 | 663篇 |
2006年 | 613篇 |
2005年 | 524篇 |
2004年 | 500篇 |
2003年 | 482篇 |
2002年 | 407篇 |
2001年 | 89篇 |
2000年 | 103篇 |
1999年 | 124篇 |
1998年 | 72篇 |
1997年 | 46篇 |
1996年 | 45篇 |
1995年 | 36篇 |
1994年 | 39篇 |
1993年 | 31篇 |
1992年 | 50篇 |
1991年 | 46篇 |
1990年 | 43篇 |
1989年 | 50篇 |
1988年 | 44篇 |
1987年 | 29篇 |
1986年 | 32篇 |
1985年 | 22篇 |
1984年 | 30篇 |
1983年 | 22篇 |
1982年 | 16篇 |
1981年 | 11篇 |
1976年 | 9篇 |
1974年 | 10篇 |
1973年 | 11篇 |
1971年 | 10篇 |
1970年 | 13篇 |
1969年 | 12篇 |
1966年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
91.
Andrea Facchini Adriana Rita Mariani Stefano Papa Erminia Mariani Francesco Antonio Manzoli 《Immunology letters》1984,8(4):207-210
Human T lymphocyte subsets, identified by means of OKT3, 4 and 8 monoclonal antibodies, were isolated by a fluorescence activated cell sorter (FACS IV) and analyzed for distribution of alpha-naphthyl acetate esterase (ANAE) activity. As compared to OKT8+ lymphocytes a higher proportion of OKT4+ lymphocytes was ANAE-positive exibiting a spot or dot-like pattern in the cytoplasm. OKT8 and 4 positive subsets showed a similar ANAE distribution in diffuse granular form. Although OKT4 and OKT8 populations presented a different ANAE dot-like reactivity, this marker did not allow as clear a distinction between them as that reported for TG and TM lymphocytes. 相似文献
92.
Comparative Analysis of Apoptosis and Inflammation Genes of Mice and Humans 总被引:4,自引:0,他引:4
下载免费PDF全文
![点击此处可从《Genome research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
John C. Reed Kutbuddin Doctor Ana Rojas Juan M. Zapata Christian Stehlik Loredana Fiorentino Jason Damiano Wilfried Roth Shu-ichi Matsuzawa Ruchi Newman Shinichi Takayama Hiroyuki Marusawa Famming Xu Guy Salvesen RIKEN GER Group GSL Members Adam Godzik 《Genome research》2003,13(6B):1376-1388
Apoptosis (programmed cell death) plays important roles in many facets of normal mammalian physiology. Host-pathogen interactions have provided evolutionary pressure for apoptosis as a defense mechanism against viruses and microbes, sometimes linking apoptosis mechanisms with inflammatory responses through NFκB induction. Proteins involved in apoptosis and NFκB induction commonly contain evolutionarily conserved domains that can serve as signatures for identification by bioinformatics methods. Using a combination of public (NCBI) and private (RIKEN) databases, we compared the repertoire of apoptosis and NFκB-inducing genes in humans and mice from cDNA/EST/genomic data, focusing on the following domain families: (1) Caspase proteases; (2) Caspase recruitment domains (CARD); (3) Death Domains (DD); (4) Death Effector Domains (DED); (5) BIR domains of Inhibitor of Apoptosis Proteins (IAPs); (6) Bcl-2 homology (BH) domains of Bcl-2 family proteins; (7) Tumor Necrosis Factor (TNF)-family ligands; (8) TNF receptors (TNFR); (9) TIR domains; (10) PAAD (PYRIN; PYD, DAPIN); (11) nucleotide-binding NACHT domains; (12) TRAFs; (13) Hsp70-binding BAG domains; (14) endonuclease-associated CIDE domains; and (15) miscellaneous additional proteins. After excluding redundancy due to alternative splice forms, sequencing errors, and other considerations, we identified cDNAs derived from a total of 227 human genes among these domain families. Orthologous murine genes were found for 219 (96%); in addition, several unique murine genes were found, which appear not to have human orthologs. This mismatch may be due to the still fragmentary information about the mouse genome or genuine differences between mouse and human repertoires of apoptotic genes. With this caveat, we discuss similarities and differences in human and murine genes from these domain families. 相似文献
93.
Chiaravalli AM Furlan D Facco C Tibiletti MG Dionigi A Casati B Albarello L Riva C Capella C 《Virchows Archiv : an international journal of pathology》2001,438(1):39-48
Alterations of DNA mismatch repair (MMR) genes are involved in carcinogenesis of sporadic and inherited human cancers characterised by instability of DNA microsatellite sequences (MSI). MSI tumours are usually identified using molecular analysis. In the present investigation, hMLH1 and hMSH2 immunohistochemistry was tested in order to evaluate the utility of this method in predicting MMR deficiency. Colorectal (72), gastric (68), endometrial (44) and ovarian (17) carcinomas were independently evaluated for familial history, histological type of tumour, MSI status and immunohistochemical results. Loss of expression of either hMLH1 or hMSH2 was observed in 51 of 55 (92.8%) MSI tumours, while 145 of 146 microsatellite stable (MSS) tumours expressed both the hMLH1 and hMSH2 gene products. Independently of tumour site, an overall agreement between immunohistochemical and molecular results was observed in 15 hereditary non-polyposis colorectal cancer-related tumours. Among sporadic tumours, only 2 of 60 colorectal and 2 of 66 gastric carcinomas, displaying MSI, expressed both hMLH1 and hMSH2 gene products. All 39 endometrial and 16 ovarian tumours presented a concordant molecular and immunohistochemical profile. These data show that immunohistochemistry is an accurate and rapid method to predict the presence of defective DNA MMR genes and to identify both sporadic and familial MSI tumours. 相似文献
94.
Gislene R. Amirato Juliana O. Borges Daniella L. Marques Juliana M. B. Santos Carlos A. F. Santos Marilia S. Andrade Guilherme E. Furtado Marcelo Rossi Lais N. Luis Raquel F. Zambonatto Eliane B. da Silva Sarah O. Poma Mariana M. de Almeida Renato L. Pelaquim Laiane C. dos Santos-Oliveira Vinicius L. Sousa Diniz Maria E. P. Passos Adriana C. Levada-Pires Renata Gorjo Marcelo P. Barros Andr L. L. Bachi Tania C. Pithon-Curi 《Nutrients》2021,13(3)
We investigated the effects of oral L-glutamine (Gln) supplementation, associated or not with physical exercises, in control of glycemia, oxidative stress, and strength/power of knee muscles in elderly women. Physically active (n = 21) and sedentary (n = 23) elderly women aged 60 to 80 years were enrolled in the study. Plasma levels of D-fructosamine, insulin, reduced (GSH) and oxidized (GSSG) glutathione, iron, uric acid, and thiobarbituric acid-reactive substances (TBARs) (lipoperoxidation product), as well as knee extensor/flexor muscle torque peak and average power (isokinetic test), were assessed pre- and post-supplementation with Gln or placebo (30 days). Higher plasma D-fructosamine, insulin, and iron levels, and lower strength/power of knee muscles were found pre-supplementation in the NPE group than in the PE group. Post-supplementation, Gln subgroups showed higher levels of GSH, GSSG, and torque peak, besides lower D-fructosamine than pre-supplementation values. Higher muscle average power and plasma uric acid levels were reported in the PE + Gln group, whereas lower insulin levels were found in the NPE + Gln than pre-supplementation values. TBARs levels were diminished post-supplementation in all groups. Gln supplementation, mainly when associated with physical exercises, improves strength and power of knee muscles and glycemia control, besides boosting plasma antioxidant capacity of elderly women. 相似文献
95.
Adriana Mika Lukasz P Halinski Tomasz Sledzinski Sylwia Malgorzewicz Paulina Woloszyk Jolanta Dardzinska Alicja Debska-Slizien Michal Chmielewski 《Nutrients》2021,13(3)
Patients with end-stage kidney disease, treated with renal transplantation, are at increased risk of cardio-vascular disease (CVD) and cardio-vascular mortality. They are also characterized by an atherogenic dyslipidemia. Alterations of the fatty acids (FA) profile contribute to increased cardio-vascular risk in the general population. In the current study we test the hypothesis that kidney transplantation is associated with ab-normalities in FA profile. FA profile was analysed by gas chromatography–mass spectrometry in 198 renal transplant recipients, and 48 control subjects. The most profound differences between renal transplant patients and controls were related to the content of branched chain FA, monounsaturated FA, and n-6 polyunsaturated FA, respectively. The FA profile significantly separated the patients from the controls in the principal component analysis (PCA). The abnormalities of FA profile showed a tendency for normalization in long-term kidney recipients, as compared to patients with recent transplants. The n-3 PUFA content demonstrated a strong inverse association with the presence of inflammation. Most profound alterations of the FA profile were observed in patients with impaired graft function (glomerular filtration rate < 45 mL/min). The study demonstrated significant disorders of the FA profile in kidney transplant recipients, that might contribute to cardio-vascular risk in this vulnerable patient population. 相似文献
96.
Karla MacDonald-Ramos Alejandra Martínez-Ibarra Adriana Monroy Juan Miranda-Ríos Marco Cerbn 《Nutrients》2021,13(6)
Dietary fatty acids (DFAs) play key roles in different metabolic processes in humans and other mammals. DFAs have been considered beneficial for health, particularly polyunsaturated (PUFAs) and monounsaturated fatty acids (MUFAs). Additionally, microRNAs (miRNAs) exert their function on DFA metabolism by modulating gene expression, and have drawn great attention for their potential as biomarkers and therapeutic targets. This review explicitly examined the effects of DFAs on miRNA expression associated with metabolic diseases, such as obesity, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease (CVD), as well as inflammation, published in the last ten years. DFAs have been shown to induce and repress miRNA expression associated with metabolic disease and inflammation in different cell types and organisms, both in vivo and in vitro, depending on varying combinations of DFAs, doses, and the duration of treatment. However, studies are limited and heterogeneous in methodology. Additionally, recent studies demonstrated that high fat ketogenic diets, many enriched with saturated fats, do not increase serum saturated fat content in humans, and are not associated with increased inflammation. Thus, these findings shed light on the complexity of novel treatment and DFA interventions for metabolic disease and to maintain health. Further studies are needed to advance molecular therapeutic approaches, including miRNA-based strategies in human health and disease. 相似文献
97.
Nestler Sebastian Grüne Britta Schilchegger Lydia Suna Adriana Perez Anita Neisius Andreas 《International urology and nephrology》2021,53(11):2267-2272
International Urology and Nephrology - To assess the efficacy of prophylaxis for urinary tract infections (UTI) in a two-year follow-up in women with StroVac compared to a therapy with... 相似文献
98.
Marysol Luna Jason D Guss Laura S Vasquez-Bolanos Macy Castaneda Manuela Vargas Rojas Jasmin M Strong Denise A Alabi Sophie D Dornevil Jacob C Nixon Erik A Taylor Eve Donnelly Xueyan Fu M Kyla Shea Sarah L Booth Rodrigo Bicalho Christopher J Hernandez 《Journal of bone and mineral research》2021,36(9):1823-1834
Modifications to the constituents of the gut microbiome influence bone density and tissue-level strength, but the specific microbial components that influence tissue-level strength in bone are not known. Here, we selectively modify constituents of the gut microbiota using narrow-spectrum antibiotics to identify components of the microbiome associated with changes in bone mechanical and material properties. Male C57BL/6J mice (4 weeks) were divided into seven groups (n = 7–10/group) and had taxa within the gut microbiome removed through dosing with: (i) ampicillin; (ii) neomycin; (iii) vancomycin; (iv) metronidazole; (v) a cocktail of all four antibiotics together (with zero-calorie sweetener to ensure intake); (vi) zero-calorie sweetener only; or (vii) no additive (untreated) for 12 weeks. Individual antibiotics remove only some taxa from the gut, while the cocktail of all four removes almost all microbes. After accounting for differences in geometry, whole bone strength was reduced in animals with gut microbiome modified by neomycin (−28%, p = 0.002) and was increased in the group in which the gut microbiome was altered by sweetener alone (+39%, p < 0.001). Analysis of the fecal microbiota detected seven lower-ranked taxa differentially abundant in animals with impaired tissue-level strength and 14 differentially abundant taxa associated with increased tissue-level strength. Histological and serum markers of bone turnover and trabecular bone volume per tissue volume (BV/TV) did not differ among groups. These findings demonstrate that modifications to the taxonomic components of the gut microbiome have the potential to decrease or increase tissue-level strength of bone independent of bone quantity and without noticeable changes in bone turnover. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
99.
Annals of Surgical Oncology - 相似文献
100.
Diana Lüftner Andreas D. Hartkopf Michael P. Lux Friedrich Overkamp Hans Tesch Adriana Titzmann Patrik Pschke Markus Wallwiener Volkmar Müller Matthias W. Beckmann Erik Belleville Wolfgang Janni Tanja N. Fehm Hans-Christian Kolberg Johannes Ettl Diethelm Wallwiener Andreas Schneeweiss Sara Y. Brucker Peter A. Fasching 《Breast care (Basel, Switzerland)》2021,16(2):108
BackgroundThe therapeutic armamentarium for patients with metastatic breast cancer is becoming more and more specific. Recommendations from clinical trials are not available for all treatment situations and patient subgroups, and it is therefore important to collect real-world data.SummaryTo develop recommendations for up-to-date treatments and participation in clinical trials for patients with metastatic breast cancer, the Prospective Academic Translational Research PRAEGNANT Network was established to optimize the quality of oncological care in the advanced therapeutic setting. The main aim of PRAEGNANT is to systematically record medical care for patients with metastatic breast cancer in the real-life setting, including the outcome and side effects of different treatment strategies, to monitor quality-of-life changes during therapy, to identify patients eligible for participation in clinical studies, and to allow targeted therapies based on the molecular structures of breast carcinomas.Key MessagesThis article describes the PRAEGNANT network and sheds light on the question of whether the various end points from clinical trials can be transferred to the real-world treatment situation. 相似文献